Sarah Guégan

6PUBLICATIONS
67CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Other chemical sciences not elsewhere classifiedNutritional epidemiologyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 09, 2026
ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype.

|Oct 24, 2025
Genetic landscape of non-UV-induced cutaneous squamous cell carcinomas.

Carmen Al Youssef, Mansour Alkobtawi, Rémi Safi

|Aug 07, 2021
Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature.

E Annabi, N Dupin, P Sohier

|Jun 12, 2020
Increased risk of permanent stoma in Crohn's disease associated with hidradenitis suppurativa: a case-control study.

Louis-Marie Dumont, Cécilia Landman, Harry Sokol

|Apr 15, 2020
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma.

David Balakirouchenane, Sarah Guégan, Chantal Csajka

|Jun 21, 2019
Encephalitis induced by immune checkpoint inhibitors in metastatic melanoma: a monocentric retrospective study.

S Galmiche, C Lheure, N Kramkimel

Pageof 1

Frequent Collaborators

2 joint publications

Bénédicte Oulès

2 joint publications

Ouidad Zehou

1 joint publications

David Balakirouchenane

1 joint publications

Alicja Puszkiel